Intended for healthcare professionals

News

Transgender care: BMA adopts neutral position on Cass review after backlash from members

BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q2137 (Published 30 September 2024) Cite this as: BMJ 2024;386:q2137
  1. Ingrid Torjesen
  1. London

The BMA has retracted its call for the UK government to lift the ban on prescribing puberty blockers to under 18s with gender dysphoria while the association conducts an evaluation of the Cass review’s recommendations.

After pressure from members and from other doctors and clinicians the BMA has confirmed that it will now take a neutral position on the recommendations while it carries out its evaluation.

The BMA called for the ban on the use of puberty blockers to be lifted on 31 July after the …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription